A multi-omics approach to liver diseases: integration of Single Nuclei Transcriptomics with Proteomics and Hi-Cap Bulk Data in human liver
Ontology highlight
ABSTRACT: Most of the metabolic functions in the human body happen in the liver, which is the largest solid organ and is composed of diverse cell types. Here we used single nuclei RNA-seq (snRNA-seq) to explore the gene expression profiles of these discrete liver cell populations. We identified seven distinct sub-populations including hepatocytes, sinusoidal endothelial cells, cholangiocytes, Kupffer cells, Nk/T/B cells, cells of nervous/arterial origin and both activated and inactive hepatic stellate cells. We then focused on medical relevant genes associated to metabolism of cancer drugs and survival of hepatocellular carcinoma (HCC). We integrated snRNA-seq with long-range genomic interactions to identify putative candidate regulatory elements for these genes and mass spectrometry proteomics to evaluate their protein abundance. We identified a new putative polymorphic regulatory element for the DPYD gene that is involved in cancer drug toxicity and a complex regulatory network for the SLC2A2 gene, which is overexpressed in HCC. Our results highlight the potential of a multi-omics approach in the study of human diseases.
PROVIDER: PRJEB36609 | ENA |
REPOSITORIES: ENA
ACCESS DATA